Evidence map›Paper›PMID 32417311›Full record

ArticleThe Journal of infection2020

The role of serology for COVID-19 control: Population, kinetics and test performance do matter.

Marie Tré-Hardy, Laurent Blairon, Alain Wilmet, Ingrid Beukinga, Hugues Malonne, Jean-Michel Dogné, Jonathan Douxfils

Open access · bronzeAbstract readLetter
In one paragraph

Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Marie Tré-HardyDepartment of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium; Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium; Department of Pharmacy, NAmur Research Institute for LIfes Sciences, University of Namur, Belgium.
Laurent BlaironDepartment of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium.
Alain WilmetDepartment of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium.
Ingrid BeukingaDepartment of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium.
Hugues MalonneFederal Agency for Medicines and Healthcare Products, Brussels, Belgium; Unit of Pharmacology, Pharmacotherapy and Pharmaceutical care, Faculty of Pharmacy, Université libre de Bruxelles, Brussels, Belgium; Department of Biomedical Sciences, NAmur Research Institute for Lifes Sciences, University of Namur, Belgium.
Jean-Michel DognéDepartment of Pharmacy, NAmur Research Institute for LIfes Sciences, University of Namur, Belgium.
Jonathan DouxfilsDepartment of Pharmacy, NAmur Research Institute for LIfes Sciences, University of Namur, Belgium; Qualiblood sa, Namur, Belgium. Electronic address: jonathan.douxfils@unamur.be.
Hôpitaux Iris Sud · BEUniversity of Namur · BEUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Serologic TestsAntibodies, ViralBetacoronavirusCoronavirus InfectionsCOVID-19False Negative ReactionsHumansKineticsPandemicsPneumonia, ViralSARS-CoV-2Sensitivity and SpecificityTime FactorsAntibodies, Viral

Identifiers

PMID32417311
PMCPMC7228733
OpenAlexW3024428857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.